EY 2014 H1

EY has leapt up our ratings, but the jury is still out on whether they’ll be able to hold the spot: did they simply get lucky this
time round (ie, did we review a higher-than-average proportion of the good stuff), or is there something more sustainable
happening behind the scenes?
The team arguing for ‘lucky’ point to the consistency of the material we reviewed – or rather the lack thereof: material

EY 2015 H1

EY continues to bounce around our table due to the high variability of its content. While we saw no outstanding content
(scoring 12 or more points under our rating criteria), we could point to examples in this sample that sit everywhere from ’a
good piece of thought leadership’ to ’this could actually be detrimental to the brand’.

EY 2014 H2

As we suspected might happen, EY’s score has dropped again this review. The firm produces an awful lot of material – some of which is very good, some of which is fairly poor. One of the higher-scoring pieces this time is Beyond borders, a report targeting the biotechnology industry. We accept that it is rather on the hefty side, but it’s easy to navigate, allowing readers to dip in to areas of interest.

Pages